Department of Chemistry, Indian Institute of Technology Bombay, Powai, Mumbai 400076, India.
Dalton Trans. 2010 May 7;39(17):4232-42. doi: 10.1039/b919036h. Epub 2010 Mar 25.
The paramagnetic ruthenium-biimidazole complexes [(acac)(2)Ru(III)(LH(-))] (1 = red-brown), (acac)(2)Ru(III)(LH(2)) (2 = pink) and Bu(4)N[(acac)(2)Ru(III)(L(2-))] (3 = greenish yellow) comprising of monodeprotonated, neutral and bideprotonated states of the coordinated biimidazole ligand (LH(n), n = 1, 2, 0), respectively, have been isolated (acac(-) = acetylacetonate). Single-crystal X-ray diffraction of 1 reveals that the asymmetric unit consists of three independent molecules: A-C, where molecule A corresponds to complex 1 and the other two molecules B and C co-exist as a hydrogen bonded dimeric unit perhaps between the cationic 2(+) and anionic 3(-). The packing diagram further reveals that the molecule A in the crystal of 1 also forms a hydrogen bonded dimer with the neighbouring another unit of molecule A. The formation of (acac)(2)Ru(III)(LH(2)) (2) has also been authenticated independently by its single-crystal X-ray structure. The packing diagram of 2 shows multiple hydrogen bonds between the N-H protons of coordinated LH(2) and the counter ClO(4)(-). Paramagnetic complexes show (1)H NMR spectra over a wide range of chemical shift, delta (ppm), +10 to -35 in CDCl(3). One-electron paramagnetic 1-3 (mu/B.M. approximately 1.9) exhibit distinct rhombic-EPR spectra with relatively large g anisotropic factors:
顺磁的钌-双咪唑配合物[(acac)(2)Ru(III)(LH(-))] (1 = 红棕色)、(acac)(2)Ru(III)(LH(2)) (2 = 粉红色)和 Bu(4)N[(acac)(2)Ru(III)(L(2-))] (3 = 绿黄色),分别包含配位双咪唑配体的单去质子化、中性和双去质子化态(LH(n), n = 1, 2, 0),已被分离出来(acac(-) = 乙酰丙酮根)。1 的单晶 X 射线衍射表明,不对称单元由三个独立的分子组成:A-C,其中分子 A 对应于配合物 1,而另外两个分子 B 和 C 则以可能在阳离子 2(+)和阴离子 3(-)之间的氢键二聚体形式共存。堆积图进一步表明,晶体中的分子 A 也与相邻的另一个分子 A 形成氢键二聚体。(acac)(2)Ru(III)(LH(2)) (2)的形成也通过其单晶 X 射线结构得到了独立的验证。2 的堆积图显示了配位 LH(2)的 N-H 质子与抗衡 ClO(4)(-)之间的多个氢键。顺磁配合物在 CDCl(3)中显示出宽化学位移范围(ppm),从+10 到-35 的(1)H NMR 谱。一电子顺磁体 1-3 (μ/B.M.约 1.9)表现出明显的菱形 EPR 谱,具有相对较大的 g 各向异性因子: